kaiser permanente glp 1 GLP-1/Ozempic coverage update : r/KaiserPermanente kaiser permanente glp-1 coverage policy

AEs leading to trial product discontinuation occurred in 2/62 (3%) participants in the CagriSema 2.4 mg/2.4 mg group, 2/63 (3%) participants in the CagriSema 1 mg/1 mg group, and 2/64 (3%) participants in the placebo group

May support normal cardiovascular function

Quantitation of selective autophagic protein aggregate degradation in vitro and in vivo using luciferase reporters

This stack could theoretically: Suppress appetite more effectively than semaglutide Enhance calorie burn via glucagon activation Preserve lean mass while reducing fat mass Stabilize hunger hormones for long-term maintenance In early data and preclinical models, this combination produced unprecedented fat-loss percentages, suggesting a paradigm shift in obesity medicine